Researchers develop new drug for aggressive leukemias
UF researchers have created a drug that effectively kills aggressive leukemia cells by targeting two proteins that promote the cancer’s growth.
All Posts by
UF researchers have created a drug that effectively kills aggressive leukemia cells by targeting two proteins that promote the cancer’s growth.
Dr. Seligson's appointment became official on July 1.
Dr. Larisa Cavallari joined News4JAX TV to discuss a new clinical trial focused on chronic acid reflux.
The study involving UF College of Pharmacy researchers will be the first to examine whether genotype-guided dosing of proton pump inhibitor medications can improve treatment outcomes for erosive esophagitis.
American Heart Association fellowships are awarded to physicians, scientists and other health care professionals whose scientific and professional accomplishments contribute to the organization’s mission and improve human health.
The blog series highlights how an interdisciplinary research collaboration involving Dr. Jatinder Lamba's lab led to the identification of a rare genomic phenomenon underlying CD33-negative AML.
The college’s investigators earned $19.4 million in NIH awards in 2025, according to the Blue Ridge Institute for Medical Research.
The three-year professorship appointment acknowledges Duarte’s career achievements while recognizing his continued ascent as a leader in precision medicine research.
PARADIGM at UF invites applications for its postdoctoral fellowship program in genomic medicine.
Every student in Dr. Jatinder Lamba’s lab who submitted an abstract earned an ASH award.